Lechleiter
Lilly to go ‘on offense’
January 31, 2014Sales and Marketing Alimta, Lechleiter, cymbalta, lilly, q4, zyprexa
The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …
Lechleiter wants policy that spurs innovation
June 8, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Lechleiter, Obama, PhRMA, US, heathcare, lilly
Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
